Wolf GT - Search Results

1

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.

Luo X, Donnelly CR, Gong W, Heath BR, Hao Y, Donnelly LA, Moghbeli T, Tan YS, Lin X, Bellile E, Kansy BA, Carey TE, Brenner JC, Cheng L, Polverini PJ, Morgan MA, Wen H, Prince ME, Ferris RL, Xie Y, Young S, Wolf GT, Chen Q, Lei YL. Luo X, et al. Among authors: wolf gt. J Clin Invest. 2020 Apr 1;130(4):1635-1652. doi: 10.1172/JCI129497. J Clin Invest. 2020. PMID: 31874109 Free PMC article.

2

Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.

Wolf GT, Carey TE. Wolf GT, et al. J Natl Cancer Inst Monogr. 1992;(13):67-74. J Natl Cancer Inst Monogr. 1992. PMID: 1389697

3

Regulation of expression and phosphorylation of A9/alpha 6 beta 4 integrin in normal and neoplastic keratinocytes.

Carey TE, Laurikainen L, Nair TS, Reinke TS, Coling DE, Wolf GT, Van Waes C, Liebert M, Marcelo C. Carey TE, et al. Among authors: wolf gt. J Natl Cancer Inst Monogr. 1992;(13):75-86. J Natl Cancer Inst Monogr. 1992. PMID: 1389698

4

In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck.

Grénman R, Carey TE, McClatchey KD, Wagner JG, Pekkola-Heino K, Schwartz DR, Wolf GT, Lacivita LP, Ho L, Baker SR, et al. Grénman R, et al. Among authors: wolf gt. Cancer. 1991 Jun 1;67(11):2741-7. doi: 10.1002/1097-0142(19910601)67:11<2741::aid-cncr2820671105>3.0.co;2-s. Cancer. 1991. PMID: 2025837

5

Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.

Wolf GT, Carey TE, Schmaltz SP, McClatchey KD, Poore J, Glaser L, Hayashida DJ, Hsu S. Wolf GT, et al. J Natl Cancer Inst. 1990 Oct 3;82(19):1566-72. doi: 10.1093/jnci/82.19.1566. J Natl Cancer Inst. 1990. PMID: 2119437

6

Squamous carcinoma of the head and neck in organ transplant recipients: possible role of oncogenic viruses.

Bradford CR, Hoffman HT, Wolf GT, Carey TE, Baker SR, McClatchey KD. Bradford CR, et al. Among authors: wolf gt. Laryngoscope. 1990 Feb;100(2 Pt 1):190-4. doi: 10.1288/00005537-199002000-00016. Laryngoscope. 1990. PMID: 2153884

7

Tamoxifen therapy in patients with recurrent laryngeal squamous carcinoma.

Urba SG, Carey TE, Kudla-Hatch V, Wolf GT, Forastiere AA. Urba SG, et al. Among authors: wolf gt. Laryngoscope. 1990 Jan;100(1):76-8. doi: 10.1288/00005537-199001000-00015. Laryngoscope. 1990. PMID: 2403448 Review.

8

Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma.

Carey TE, Wolf GT, Hsu S, Poore J, Peterson K, McClatchey KD. Carey TE, et al. Among authors: wolf gt. Otolaryngol Head Neck Surg. 1987 Mar;96(3):221-30. doi: 10.1177/019459988709600301. Otolaryngol Head Neck Surg. 1987. PMID: 3108804

9

Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region.

Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE. Van Dyke DL, et al. Among authors: wolf gt. Genes Chromosomes Cancer. 1994 Mar;9(3):192-206. doi: 10.1002/gcc.2870090308. Genes Chromosomes Cancer. 1994. PMID: 7515662

10

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.

Bradford CR, Zhu S, Wolf GT, Poore J, Fisher SG, Beals T, McClatchey KD, Carey TE. Bradford CR, et al. Among authors: wolf gt. Otolaryngol Head Neck Surg. 1995 Oct;113(4):408-12. doi: 10.1016/s0194-5998(95)70077-3. Otolaryngol Head Neck Surg. 1995. PMID: 7567013 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page